Evidence map›Paper›PMID 41525420›Full record

ArticlePLoS neglected tropical diseases2026

Evaluating the impact of nitisinone at mosquito-lethal doses on Lutzomyia longipalpis.

Laure Augendre, Lucas Alexandre Farias de Souza, Magda Clara Vieira da Costa Ribeiro, Jérôme Depaquit, Jean-Philippe Martinet, Jorian Prudhomme

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Laure AugendreUR ESCAPE Epidemiosurveillance and circulation of parasites in the environment, University of Reims Champagne-Ardenne, Faculty of Pharmacy, Reims, France.ORCID https://orcid.org/0000-0002-6271-1508
Lucas Alexandre Farias de SouzaInsects Vectors and Parasites Laboratory, Department of Basic Pathology and Postgraduate program in Microbiology, Parasitology and Pathology, Federal University of Paraná, Curitiba, Brazil.
Magda Clara Vieira da Costa RibeiroInsects Vectors and Parasites Laboratory, Department of Basic Pathology and Postgraduate program in Microbiology, Parasitology and Pathology, Federal University of Paraná, Curitiba, Brazil.
Jérôme DepaquitUR ESCAPE Epidemiosurveillance and circulation of parasites in the environment, University of Reims Champagne-Ardenne, Faculty of Pharmacy, Reims, France.
Jean-Philippe MartinetUR ESCAPE Epidemiosurveillance and circulation of parasites in the environment, University of Reims Champagne-Ardenne, Faculty of Pharmacy, Reims, France.
Jorian PrudhommeUR ESCAPE Epidemiosurveillance and circulation of parasites in the environment, University of Reims Champagne-Ardenne, Faculty of Pharmacy, Reims, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitisinone, a systemic inhibitor of tyrosine catabolism, has recently emerged as a promising endectocide with demonstrated lethality against mosquitoes and tsetse flies. To assess its efficacy against Lutzomyia longipalpis, an important vector of Leishmania infantum -the causative agent of zoonotic visceral leishmaniasis prevalent in the Mediterranean basin, Latin America, and parts of the Middle East-, we exposed sand flies to a concentration previously shown to be lethal to Anopheles mosquitoes (250 ng/mL). Survival was monitored over 14 days and showed no significant difference between treated and control groups, indicating a lack of insecticidal effect at this dose. These findings suggest that Lu. longipalpis exhibits tolerance to nitisinone, likely due to species-specific metabolic differences. Although nitisinone remains a promising tool for systemic vector control, its effectiveness against sand flies may require higher doses or alternative compounds.

Indexed as

CyclohexanonesInsecticidesPsychodidaeAnimalsFemaleInsect VectorsSurvival AnalysisCyclohexanonesInsecticides

Identifiers

PMID41525420
PMCPMC12822919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.